专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010067984A2 NOVEL BIOMARKER FOR LIVER CANCER AND APPLICATIONS FOR SAME 审中-公开
标题翻译：新的肝癌生物标志物及其应用
公开(公告)号：WO2010067984A2
公开(公告)日：2010-06-17
申请号：PCT/KR2009007202
申请日：2009-12-03
申请人： KOREA RES INST OF BIOSCIENCE , SONG EUN YOUNG , LEE HEE GU , YEOM YOUNG IL , JI NA YOUNG , LEE JUNG IL , KANG MIN A , KIM YOUNG JOO , KANG YOON HEE , KIM JAE WHA
发明人： SONG EUN YOUNG , LEE HEE GU , YEOM YOUNG IL , JI NA YOUNG , LEE JUNG IL , KANG MIN A , KIM YOUNG JOO , KANG YOON HEE , KIM JAE WHA
IPC分类号： C12Q1/68 , C12N15/12 , G01N33/574
CPC分类号： C07K14/4748 , C12Q1/6886 , C12Q2600/158 , G01N33/57438 , G01N2800/50
摘要： The present invention relates to the elucidation of a gene that can act as a novel marker for liver cancer diagnosis and to diagnostic and prognostic measurements of liver cancer using the same. More specifically, it relates to a diagnosis kit that enables diagnostic and prognostic measurement of a liver cancer using a preparation that measures expression levels of at least one gene selected from a group of liver cancer diagnosis markers consisting of S100P, NK4, CCL20, CSPG2, PLAU, MMP12, ESM-1, ABHD7, HCAPG, CXCL-3, Col5A2, MAGEA, GSN, CDC2, CST1, MELK, ATAD2, FAP and MSN and/or a method for diagnostic and prognostic measurement of liver cancer using the same. These have been discovered using normal liver tissues and liver cancer tissues collected from the same liver cancer patient of the present invention and represent the markers whose accuracy and reliability have been greatly improved as markers of liver cancer. The markers of the present invention can be used for the accurate diagnosis and prognosis of liver cancer.
摘要翻译：本发明涉及可用作肝癌诊断的新型标志物的基因的阐明以及使用其的肝癌的诊断和预后测量。更具体而言，涉及一种诊断试剂盒，其能够使用测定选自由S100P，NK4，CCL20，CSPG2等组成的肝癌诊断标志物组中的至少一个基因的表达量的制剂，进行肝癌的诊断和预后测定。 PLA12，MMP12，ESM-1，ABHD7，HCAPG，CXCL-3，Col5A2，MAGEA，GSN，CDC2，CST1，MELK，ATAD2，FAP和MSN和/或使用其诊断和预测肝癌的方法。已经发现使用从本发明的相同肝癌患者采集的正常肝组织和肝癌组织，并且代表了其准确性和可靠性作为肝癌标志物已经大大提高的标志物。本发明的标记物可用于肝癌的准确诊断和预后。

2. 发明申请

WO2012011778A3 CANCER DIAGNOSIS KIT AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER 审中-公开
标题翻译：癌症诊断试剂盒和药物组合物预防或治疗癌症
公开(公告)号：WO2012011778A3
公开(公告)日：2012-05-24
申请号：PCT/KR2011005433
申请日：2011-07-22
申请人： KOREA RES INST OF BIOSCIENCE , CHUNG KYUNG SOOK , WON MI SUN , AHN JI WON , KIM YOUNG JOO , SONG EUN YOUNG , YEOM YOUNG IL , LEE HEE GU
发明人： CHUNG KYUNG SOOK , WON MI SUN , AHN JI WON , KIM YOUNG JOO , SONG EUN YOUNG , YEOM YOUNG IL , LEE HEE GU
IPC分类号： C12Q1/68 , A61K48/00 , C12N15/12 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574
摘要： The present invention relates to a composition for cancer diagnosis having a formulation for measuring the expression level of Chromosome 10 open reading frame 81 (C10orf81) gene mRNA or protein thereof, a kit for cancer diagnosis having the composition, a method for providing information on cancer diagnosis including a step for measuring the expression level of C10orf81 gene mRNA or the expression level of protein coded by the gene, and a method for screening pharmaceutical compositions for the prevention or the treatment of cancer including an expression inhibitor for the C10orf81 gene or an activity inhibitor for the protein thereof, and therapeutic agents for cancer. The present invention enables an accurate diagnosis of cancer by providing genes specific to stomach cancer, liver cancer, colorectal cancer, lung cancer, or prostate cancer, and diagnostic markers for determining the metastasis and prognosis of the cancer, and can be useful in the diagnosis and prognosis management of cancer. Also, the present invention enables the development of new bio-medicines having fewer side effects and customized anticancer drugs by providing a cancer-specific therapeutic agent capable of inhibiting the gene.
摘要翻译：本发明涉及用于癌症诊断的组合物，其具有用于测量染色体10开放阅读框81（C10orf81）基因mRNA或其蛋白质的表达水平的制剂，具有该组成的癌症诊断用试剂盒，提供癌症信息的方法诊断包括测量C10orf81基因mRNA的表达水平的步骤或由该基因编码的蛋白质的表达水平的步骤，以及用于筛选用于预防或治疗癌症的药物组合物的方法，包括用于C10orf81基因的表达抑制剂或活性其蛋白质的抑制剂和癌症治疗剂。本发明能够通过提供对胃癌，肝癌，结肠直肠癌，肺癌或前列腺癌特异性的基因和用于确定癌症的转移和预后的诊断标记物来准确诊断癌症，并且可用于诊断和癌症的预后管理。此外，通过提供能够抑制该基因的癌症特异性治疗剂，本发明能够开发副作用较少的新生物药物和定制的抗癌药物。

3. 发明申请

WO2012011777A2 KIT FOR DIAGNOSING COLORECTAL CANCER AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF COLORECTAL CANCER 审中-公开
标题翻译：用于诊断颜色性癌症和药物组合物的工具包，用于预防或治疗色素性癌症
公开(公告)号：WO2012011777A2
公开(公告)日：2012-01-26
申请号：PCT/KR2011005431
申请日：2011-07-22
申请人： KOREA RES INST OF BIOSCIENCE , CHUNG KYUNG SOOK , WON MI SUN , KIM YOUNG JOO , SONG EUN YOUNG , AHN JI WON , YEOM YOUNG IL , LEE HEE GU , JANG YEO-JIN
发明人： CHUNG KYUNG SOOK , WON MI SUN , KIM YOUNG JOO , SONG EUN YOUNG , AHN JI WON , YEOM YOUNG IL , LEE HEE GU , JANG YEO-JIN
IPC分类号： C12Q1/68 , A61P35/00 , C12N15/12 , G01N33/574
CPC分类号： G01N33/57419 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158
摘要： The present invention relates to: a composition for diagnosing colorectal cancer containing a formulation for measuring the expression level of a chromosome 1 open reading frame 135 (C1orf135) gene mRNA or the protein thereof; a kit for diagnosing colorectal cancer containing the composition; a method for providing information on diagnosis of colorectal cancer, the method comprising a step for measuring the expression level of a C1orf135 gene mRNA or the expression level of the protein coded by the gene; a pharmaceutical composition for the prevention or the treatment of colorectal cancer, the composition comprising an expression inhibitor for a C1orf135 gene or an activity inhibitor for the protein thereof; and a method for screening a therapeutic agent for colorectal cancer. The present invention enables the accurate diagnosis of colorectal cancer by providing a gene specific to colorectal cancer, and a diagnostic marker for determining the metastasis and prognosis of colorectal cancer, and can be useful in the diagnosis and prognosis management of colorectal cancer. Also, the present invention enables the development of new bio-medicines having fewer side effects and customized anticancer drugs by providing a colorectal cancer-specific therapeutic agent capable of inhibiting the gene.
摘要翻译：本发明涉及：用于诊断结肠直肠癌的组合物，其含有用于测量染色体1开放阅读框135（C1orf135）基因mRNA或其蛋白质的表达水平的制剂; 用于诊断含有该组合物的结肠直肠癌的试剂盒; 提供关于结肠直肠癌诊断的信息的方法，所述方法包括测定C1orf135基因mRNA的表达水平或由所述基因编码的蛋白质的表达水平的步骤。用于预防或治疗结肠直肠癌的药物组合物，所述组合物包含C1orf135基因的表达抑制剂或其蛋白质的活性抑制剂; 以及筛选结直肠癌治疗剂的方法。本发明能够通过提供对结肠直肠癌特异性的基因和用于确定结肠直肠癌的转移和预后的诊断标记物来准确诊断结肠直肠癌，并且可用于结肠直肠癌的诊断和预后管理。此外，通过提供能够抑制该基因的结肠直肠癌特异性治疗剂，本发明使得能够开发具有较少副作用的新生物药物和定制的抗癌药物。

4. 发明申请

WO2011065677A3 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER 审中-公开
标题翻译：治疗癌症的药物组合物
公开(公告)号：WO2011065677A3
公开(公告)日：2011-11-03
申请号：PCT/KR2010007600
申请日：2010-11-01
申请人： KOREA RES INST OF BIOSCIENCE , WON MISUN , CHUNG KYUNG-SOOK , KIM YOUNG JOO , HONG HYE KYUNG , YEOM YOUNG IL , YUN CHAE OK , OH YU KYUNG , SONG KYUNG BIN , LEE HEE GU , SONG EUN YOUNG , KIM YOUNG HO , KIM MOON HEE , JUNG KYEONG-EUN
发明人： WON MISUN , CHUNG KYUNG-SOOK , KIM YOUNG JOO , HONG HYE KYUNG , YEOM YOUNG IL , YUN CHAE OK , OH YU KYUNG , SONG KYUNG BIN , LEE HEE GU , SONG EUN YOUNG , KIM YOUNG HO , KIM MOON HEE , JUNG KYEONG-EUN
IPC分类号： A61K31/7105 , A61K31/711 , A61P35/00
CPC分类号： C12N15/113 , A61K31/7105 , A61K31/711 , A61K31/713 , C12N2310/531
摘要： The present invention provides a pharmaceutical composition for treating cancer, comprising at least one selected from deoxyribonucleic acids (DNA) for encoding small interfering RNA (siRNA) which complementarily binds to the base sequence of the transcript (mRNA transcript) of the FLJ25416 gene, represented by sequence number 3, sequence number 5, and sequence number 7 to inhibit the intracellular expression of the FLJ25416 gene, antisense RNA which inhibits expression of the FLJ25416 gene, and short hairpin RNA (shRNA) which inhibits expression of the FLJ25416 gene. As the siRNA, which is complementary to the base sequence of the transcript (mRNA transcript) of the FLJ25416 gene, the antisense RNA, and the shRNA, according to the present invention, inhibit expression of the FLJ25416 gene which is known to be expressed in cancer cells, and thus kill cancer cells, the composition of the present invention can be used as a novel anti-cancer agent.
摘要翻译：本发明提供用于治疗癌症的药物组合物，其包含选自用于编码与FLJ25416基因的转录物（mRNA转录物）的碱基序列互补结合的小干扰RNA（siRNA）的脱氧核糖核酸（DNA）中的至少一种，序列号3，序列号5和序列号7以抑制FLJ25416基因的细胞内表达，抑制FLJ25416基因表达的反义RNA和抑制FLJ25416基因表达的短发夹RNA（shRNA）。由于本发明的与FLJ25416基因，反义RNA和shRNA的转录物（mRNA转录物）的碱基序列互补的siRNA抑制已知表达癌细胞，从而杀死癌细胞，本发明的组合物可以用作新型的抗癌剂。

5. 发明授权

KR100692319B1 THE FINDING METHOD OF NEW DISEASE-ASSOCIATED GENES THROUGH ANALYSIS OF PROTEIN-PROTEIN INTERACTION NETWORK 无效
标题翻译：通过分析蛋白质 - 蛋白质相互作用网络的新疾病相关基因的发现方法
公开(公告)号：KR100692319B1
公开(公告)日：2007-03-02
申请号：KR20060016120
申请日：2006-02-20
申请人： KOREA RES INST OF BIOSCIENCE
发明人： KIM YOUNG JOO , HWANG SO HYUN , SON SEUNG WOO , KIM SANG CHEOL , JEONG HA WOONG , YOON YOO SIK , LEE DO HEON
IPC分类号： C12Q1/68 , C12Q1/00
CPC分类号： C12Q1/6811 , G06F19/18
摘要： A method for finding new disease-related genes is provided to select the genes related to the new disease through statistical and physical network analysis by generating protein-protein interaction network from well known disease genes and disease related literature information, gene expression information and protein interaction information. The method comprises the steps of: (a) selecting a candidate gene from document information data relating to disease-related genes; (b) identifying normality from test data of the disease-related genes' expression information provided by Online Mendelian In Man(OMIM) to select a candidate gene from significant data; (c) generating protein interaction network between the candidate genes selected from the steps(a) and (b) and protein from protein interaction information data which is Human protein reference database(HPRD); (d) analyzing nodes of the protein interaction network; and (e) making the analysis result to be scored to select disease-related genes.
摘要翻译：提供了一种寻找新的疾病相关基因的方法，通过统计和物理网络分析，通过从众所周知的疾病基因和疾病相关文献信息，基因表达信息和蛋白质相互作用产生蛋白质 - 蛋白质相互作用网络来选择与新疾病相关的基因信息。该方法包括以下步骤：（a）从涉及疾病相关基因的文献信息数据中选择候选基因; （b）从在线孟德尔人（OMIM）提供的疾病相关基因表达信息的测试数据中识别正常性，从重要数据中选择候选基因; （c）在选自步骤（a）和（b）的候选基因和蛋白质相互作用信息数据（即人蛋白质参考数据库（HPRD））之间产生蛋白质相互作用网络; （d）分析蛋白质相互作用网络的节点; 和（e）使分析结果进行评分以选择疾病相关基因。

6. 发明申请

WO2012023802A3 METHOD AND APPARATUS FOR LOCATING A SOURCE OF DAMAGE IN A LARGE COMPOSITE MATERIAL STRUCTURE 审中-公开
标题翻译：用于在大型复合材料结构中定位损伤源的方法和设备
公开(公告)号：WO2012023802A3
公开(公告)日：2012-05-03
申请号：PCT/KR2011006045
申请日：2011-08-17
申请人： KOREA RES INST OF STANDARDS , YOON DONG JIN , HAN BYEONG HEE , KIM YOUNG JOO
发明人： YOON DONG JIN , HAN BYEONG HEE , KIM YOUNG JOO
IPC分类号： G01N29/04 , G01N29/14
CPC分类号： G01N29/44 , G01N29/069 , G01N29/14 , G01N29/42 , G01N2291/0231 , G01N2291/2693
摘要： The present invention relates to a method for locating a source of damage in a blade of a wind power generator, capable of tracing the source of damage in a blade used in a wind power generator. More particularly, the present invention relates to a method and apparatus for locating a source of damage in a blade of a wind power generator, which involve detecting defects using an attenuation map prepared on the basis of energy values of elastic waves so as to accurately locate a source of damage in a large composite material structure. The method for locating a source of damage in a blade of a wind power generator according to the present invention enables a source of damage in a large composite material structure made of two or more materials to be accurately located in a different manner than conventional techniques, and fewer AE sensors to be used as compared to conventional techniques.
摘要翻译：本发明涉及一种用于定位风力发电机的叶片中的损坏源的方法，该方法能够追踪风力发电机中使用的叶片中的损伤源。更具体地说，本发明涉及一种用于定位风力发电机的叶片中的损伤源的方法和设备，该方法和设备涉及使用基于弹性波的能量值准备的衰减图来检测缺陷，以便精确定位这是大型复合材料结构中的一种损伤源。根据本发明的用于定位风力发电机的叶片中的损坏源的方法使得能够以与常规技术不同的方式精确定位由两种或更多种材料制成的大型复合材料结构中的损伤源，与传统技术相比，使用更少的AE传感器。

7. 发明申请

WO2012124903A3 DUMP-TYPE TRANSPORT CONTAINER HAVING LOCKING DEVICE 审中-公开
标题翻译：具有锁定装置的倾卸式运输集装箱
公开(公告)号：WO2012124903A3
公开(公告)日：2012-12-27
申请号：PCT/KR2012001213
申请日：2012-02-17
申请人： KOREA RAILROAD RES INST , KWON YONG JANG , KIM KYOUNG TAE , LEE SUK , KIM YOUNG JOO
发明人： KWON YONG JANG , KIM KYOUNG TAE , LEE SUK , KIM YOUNG JOO
IPC分类号： B65D88/12 , B60P1/64
CPC分类号： B65D88/123 , B60P1/26 , B65D90/623
摘要： The present invention relates to a dump-type transport container having a locking device, and more particularly, to a transport container having a locking device for preventing a door from opening and spilling loaded items when moving while carrying the loaded items in the dump-type transport container. The accommodation container of the present invention comprises: a container body for accommodating the loaded items, and which has a open top surface; a door formed on the rear surface of the container body so as to allow opening/closing thereof; and a locking portion for locking or unlocking the door from both side surfaces of the door.
摘要翻译：具有锁定装置的倾卸式运输容器技术领域本发明涉及一种具有锁定装置的倾卸式运输容器，并且更具体地涉及一种具有锁定装置的运输容器，所述锁定装置用于防止门在运输时将门上的物品打开和溢出，运输集装箱。本发明的容纳容器包括：用于容纳装载物品的容器主体，并具有敞开的顶表面; 形成在容器主体的后表面上以允许其打开/关闭的门; 以及用于从门的两侧表面锁定或解锁门的锁定部分。

8. 发明授权

KR101578637B1 연속 합성거더교용 프리스트레스트 콘크리트 거더를 이용한 연속 합성거더교의 시공 방법 有权
标题翻译：用于连续复合钢丝绳桥梁的预制混凝土梁及其构造方法
公开(公告)号：KR101578637B1
公开(公告)日：2015-12-17
申请号：KR20150077785
申请日：2015-06-02
申请人： KIM YOUNG JOO
发明人： KIM YOUNG JOO
IPC分类号： E01D2/00 , E01D21/00
摘要： 본발명은연속합성거더교용프리스트레스트콘크리트거더및 이를이용한연속합성거더교의시공방법에관한것으로서, 더욱상세하게는프리캐스트 PSC 거더들을교대및 교각등의하부구조위에설치하고바닥판을시공하기전에교각상의연속부에서거더를현장타설콘크리트로이음하고텐던을사용하여연속화를하는거더연속화시공방법에있어서연속화된거더의정모멘트작용부와부모멘트작용부의텐던을다르게구성하여구조적으로매우효율적이며긴장작업도용이하고다경간연속교에도적합한연속합성거더교용프리스트레스트콘크리트거더및 이를이용한연속합성거더교의시공방법에관한것이다. 본발명은, 프리캐스트프리스트레스트콘크리트거더들을교대및 교각등의하부구조위에설치하고바닥판을시공하기전에교각상의거더연속부에서거더를현장타설콘크리트로이음하고텐던을사용하여연속화를하는거더연속화시공방법에있어서, 연속거더의양단부에배치되는측경간용거더와상기측경간용거더의사이에배치되는중앙경간용거더를포함(중앙경간용거더는거더의수가 3개이상인경우에만포함)하며연속합성거더교에사용되는프리스트레스트콘크리트거더에있어서, 거더연속화이후에연속거더에작용하는사하중들에의한작용휨모멘트의부호가변하는변곡점주변(측경간용거더의본체에는교대로부터먼 단부쪽에위치하고, 중앙경간용거더본체에는양 단부쪽에하나씩한 쌍이존재함)에형성되는중간정착부를포함하며, 일방향으로길게제작되는철근콘크리트재질의본체; 상기본체의양단부에각각마련되는제1정착구와, 상기한 쌍의제1정착구를연결하며어느하나의제1정착구로부터본체의중앙까지는점차적으로아래로내려가다가본체의중앙부로부터다른하나의제1정착구까지는점차적으로위로올라가는곡선형상으로배치되는제1쉬스관과, 상기제1쉬스관에삽입되며인장력이가해진상태로양단부가상기한 쌍의제1정착구에각각정착되는제1텐던을포함하는제1프리스트레싱유닛; 상기측경간용거더본체의경우중간정착부로부터먼쪽의단부와상기중간정착부의에각각마련되고, 상기중앙경간용거더본체의경우상기한 쌍의중간정착부에각각마련되는제2정착구와, 상기한 쌍의제2정착구를연결하며곡선형상으로배치되는제2쉬스관과, 상기제2쉬스관에삽입되며인장력이가해진상태로양단부가상기한 쌍의제2정착구에각각정착되는제2텐던을포함하는제2프리스트레싱유닛; 서로인접한한 쌍의본체의서로접하는단부와가까이위치한한 쌍의중간정착부에각각마련되는제3정착구와, 상기한 쌍의제3정착구를연결하며곡선형상으로배치되되양단부의일정길이만큼은상기제2텐던과겹치도록배치되는제3쉬스관과, 상기제3쉬스관에삽입되며인장력이가해진상태로양단부가상기한 쌍의제3정착구에각각정착되는제3텐던을포함하는제3프리스트레싱유닛;을포함하는것을특징으로하는연속합성거더교용프리스트레스트콘크리트거더를제공한다.
摘要翻译：本发明涉及一种使用连续复合梁桥的预应力混凝土梁的连续复合梁桥的施工方法，更具体地说，涉及一种使用连续复合梁预应力混凝土梁的连续复合梁桥的施工方法桥梁，其能够通过在下部结构（例如桥台和码头）上安装预制PSC梁并使用现浇混凝土将梁连接到码头的延续部分，使用腱延伸底板结构。因此，本发明通过使用彼此不同的正矩施加部分和连续梁的负矩施加部分的腱来提高结构效率，促进张力作用，并且适用于多跨连续桥梁。

9. 发明授权

KR101528865B1 투명 베이스 네일 스티커 有权
标题翻译：透明基指甲贴
公开(公告)号：KR101528865B1
公开(公告)日：2015-06-17
申请号：KR20150032316
申请日：2015-03-09
申请人： KIM YOUNG JOO
发明人： KIM YOUNG JOO
IPC分类号： A45D31/00
CPC分类号： A45D31/00 , A45D29/001 , A45D2031/005 , A61Q3/02 , B44C1/16
摘要： 본발명은네일아트작업시손톱에칠하는베이스젤, 메니큐어, 본드등을대신해손톱에붙이는투명베이스네일스티커에관한것이다. 본발명에따른베이스젤네일스테커는원단(10)이폴리우레탄수지소재로이루어지고, 원단(10)의하부면에점착제(12)가도포되어, 원단(10)이점착제(12)에의해이형지(20)에분리가능하게부착되며, 원단(10)의상부면에나일론코팅층(14)이형성되는것을특징으로한다.
摘要翻译：本发明涉及一种透明的底部指甲贴纸，其可以附着在指甲上，而不是指甲基凝胶，指甲油和指甲胶等，它们在美甲工作期间被涂在指甲上。根据本发明的贴纸，贴纸的织物（10）由聚氨酯树脂制成，将胶水（12）施加到织物（10）的下表面，织物（10）可拆卸地连接到通过胶水（12）的隔离纸（20）和尼龙涂层（14）形成在织物（10）的上表面上。

10. 发明授权

KR100913255B1 COMPOSITION OF CEMENT MORTAR FOR REINFORCING OF SECTION AND METHOD OF USING THEREOF 有权
标题翻译：用于加固部分的水泥浆的组合物及其使用方法
公开(公告)号：KR100913255B1
公开(公告)日：2009-08-24
申请号：KR20090042097
申请日：2009-05-14
申请人： KIM YOUNG JOO , KNIX CORP , TAE KYUNG DEV CO LTD
发明人： KIM YOUNG JOO
IPC分类号： C04B24/04 , C04B16/04 , C04B16/06 , C04B24/38
CPC分类号： C04B28/06 , C04B2111/723 , C04B7/02 , C04B14/06 , C04B20/0048 , C04B22/00 , C04B22/04 , C04B24/24 , C04B38/02 , C04B2103/40 , C04B2103/65
摘要： The cement mortar composition for the cross section enforcement is provided to improve the mechanical and chemical strength corresponding to the impairing factor. The cement mortar composition comprises the Portland cement of 20~40 wt%, the inorganic expander of 3~10 wt%, the alumina cement of 5~30 wt%, the silica of 35~60 wt%, the zirconium(Zr) of 3~8 wt%, the fiber of 0.2~2.5 wt%, the polymer of 0.5~5.0 wt%, the reactivity control liquid of 0.3~2.0 wt%, the water repellent of 0.1~1.0 wt% and the surfactant of 0.3~2.0 wt%. The surfactant is one selected from the melamine system, the naphthalene system, and the carboxyl system. The fiber is selected from the nylon, polypropylene acryl, acryl amide, cellulose, PVA, and the steel. The reactivity control liquid is selected from the citric acid, sodium gluconate, tartaric acid, fluoride, methyl cellulose, ethylcellulose and the boric acid.
摘要翻译：提供了用于横截面实施的水泥砂浆组合物，以改善与损伤因素相对应的机械和化学强度。水泥砂浆组成包括20〜40重量％的波特兰水泥，3〜10重量％的无机膨胀剂，5〜30重量％的氧化铝水泥，35〜60重量％的二氧化硅，锆（Zr） 3〜8重量％，纤维为0.2〜2.5重量％，聚合物为0.5〜5.0重量％，反应性控制液为0.3〜2.0重量％，防水性为0.1〜1.0重量％，表面活性剂为0.3〜 2.0重量％。表面活性剂选自三聚氰胺体系，萘体系和羧基体系。纤维选自尼龙，聚丙烯丙烯酸，丙烯酰胺，纤维素，PVA和钢。反应性控制液体选自柠檬酸，葡萄糖酸钠，酒石酸，氟化物，甲基纤维素，乙基纤维素和硼酸。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式